American Journal of Medicine, The, ISSN 0002-9343, 2009, Volume 122, Issue 2, pp. 114 - 120
Abstract Randomized controlled trials are considered the gold standard in the hierarchy of research designs for evaluating the efficacy and safety of a...
Internal Medicine | Osteoporosis | Treatment effectiveness | Health care databases | Observational studies | Randomized controlled trials | RATIONALE | PERSISTENCE | DATABASES | ALENDRONATE | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL OSTEOPOROSIS | FRACTURES | RISEDRONATE | HEALTH-CARE | OUTCOMES | GENERALIZABILITY | Delivery of Health Care | Humans | Observation | Treatment Outcome | Research Design | Case-Control Studies | Cohort Studies | Databases, Factual | Randomized Controlled Trials as Topic | Clinical trials | Medicine, Experimental | Medical research | Usage | Analysis
Internal Medicine | Osteoporosis | Treatment effectiveness | Health care databases | Observational studies | Randomized controlled trials | RATIONALE | PERSISTENCE | DATABASES | ALENDRONATE | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL OSTEOPOROSIS | FRACTURES | RISEDRONATE | HEALTH-CARE | OUTCOMES | GENERALIZABILITY | Delivery of Health Care | Humans | Observation | Treatment Outcome | Research Design | Case-Control Studies | Cohort Studies | Databases, Factual | Randomized Controlled Trials as Topic | Clinical trials | Medicine, Experimental | Medical research | Usage | Analysis
Journal Article
American Journal of Geriatric Psychiatry, ISSN 1064-7481, 2014, Volume 22, Issue 3, pp. S69 - S70
Journal Article
3.
Full Text
Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
American Journal of Medicine, The, ISSN 0002-9343, 2009, Volume 122, Issue 2, pp. S3 - S13
Abstract Fragility fractures associated with osteoporosis constitute a significant public health concern. Clinical trials have shown that a variety of...
Internal Medicine | Adherence | Persistence | Osteoporosis | Fracture | Compliance | UNITED-STATES | DRUG-THERAPY | RISK | DATABASE ANALYSIS | ECONOMIC BURDEN | WOMEN | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL OSTEOPOROSIS | BISPHOSPHONATE THERAPY | MEDICATION COMPLIANCE | Europe - epidemiology | Osteoporosis - drug therapy | Medication Adherence | North America - epidemiology | Fractures, Spontaneous - epidemiology | Humans | Fractures | Drug therapy | Risk factors
Internal Medicine | Adherence | Persistence | Osteoporosis | Fracture | Compliance | UNITED-STATES | DRUG-THERAPY | RISK | DATABASE ANALYSIS | ECONOMIC BURDEN | WOMEN | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL OSTEOPOROSIS | BISPHOSPHONATE THERAPY | MEDICATION COMPLIANCE | Europe - epidemiology | Osteoporosis - drug therapy | Medication Adherence | North America - epidemiology | Fractures, Spontaneous - epidemiology | Humans | Fractures | Drug therapy | Risk factors
Journal Article
The Journal of the American Dental Association (JADA), ISSN 0002-8177, 2008, Volume 139, Issue 5, pp. 537 - 538
Journal Article
Rheumatic Disease Clinics of North America, ISSN 0889-857X, 08/2011, Volume 37, Issue 3, pp. 471 - 477
Teriparitide (TPD) is a novel anabolic agent that stimulates bone formation. TPD reduces risk of vertebral and nonvertebral fracture. Due to its positive...
Osteoporosis | Osteonecrosis | Postmenopausal women | Teriparitide | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | MODEL | RHEUMATOLOGY | ALENDRONATE | TERIPARATIDE TREATMENT | DOUBLE-BLIND | FRACTURES | CHONDROGENESIS | Osteoporosis, Postmenopausal - epidemiology | Teriparatide - therapeutic use | Humans | Middle Aged | Risk Factors | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporosis, Postmenopausal - drug therapy
Osteoporosis | Osteonecrosis | Postmenopausal women | Teriparitide | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | MODEL | RHEUMATOLOGY | ALENDRONATE | TERIPARATIDE TREATMENT | DOUBLE-BLIND | FRACTURES | CHONDROGENESIS | Osteoporosis, Postmenopausal - epidemiology | Teriparatide - therapeutic use | Humans | Middle Aged | Risk Factors | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporosis, Postmenopausal - drug therapy
Journal Article
Journal of Clinical Densitometry, ISSN 1094-6950, 2007, Volume 10, Issue 2, pp. S219 - S219
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2007, Volume 37, Issue 1, pp. 1 - 12
Objective To provide a review of current developments in bisphosphonates indicated for the treatment of several rheumatologic conditions, including...
Rheumatology | glucocorticoid-induced osteoporosis | bisphosphonates | postmenopausal osteoporosis | GASTROINTESTINAL-TRACT SAFETY | ONCE-WEEKLY ALENDRONATE | RANDOMIZED-TRIAL | RHEUMATOLOGY | INTRAVENOUS IBANDRONATE INJECTIONS | ZOLEDRONIC ACID | HIP FRACTURE | ACID 5 MG | VERTEBRAL FRACTURE RISK | PAGETS-DISEASE | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Animals | Humans | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis | Collagen
Rheumatology | glucocorticoid-induced osteoporosis | bisphosphonates | postmenopausal osteoporosis | GASTROINTESTINAL-TRACT SAFETY | ONCE-WEEKLY ALENDRONATE | RANDOMIZED-TRIAL | RHEUMATOLOGY | INTRAVENOUS IBANDRONATE INJECTIONS | ZOLEDRONIC ACID | HIP FRACTURE | ACID 5 MG | VERTEBRAL FRACTURE RISK | PAGETS-DISEASE | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Animals | Humans | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis | Collagen
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2009, Volume 122, Issue 2, pp. S33 - S45
Abstract Osteonecrosis of the jaw (ONJ), a condition characterized by necrotic exposed bone in the maxillofacial region, has been reported in patients with...
Internal Medicine | Osteoporosis | Intravenous bisphosphonate | Bisphosphonate treatment | Osteonecrosis of the jaw | Paget disease | RISK-FACTORS | NITROGEN-CONTAINING BISPHOSPHONATES | INFECTED OSTEORADIONECROSIS | AVASCULAR NECROSIS | ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | IN-VITRO | POSTMENOPAUSAL OSTEOPOROSIS | ALENDRONATE TREATMENT | LONG-TERM RISEDRONATE | FEMORAL-HEAD | Jaw Diseases - chemically induced | Bone Neoplasms - drug therapy | Osteonecrosis - chemically induced | Diphosphonates - adverse effects | Humans | Diphosphonates | Bones | Dosage and administration | Postmenopausal women | Drug therapy | Health aspects | Necrosis | Index Medicus | Abridged Index Medicus
Internal Medicine | Osteoporosis | Intravenous bisphosphonate | Bisphosphonate treatment | Osteonecrosis of the jaw | Paget disease | RISK-FACTORS | NITROGEN-CONTAINING BISPHOSPHONATES | INFECTED OSTEORADIONECROSIS | AVASCULAR NECROSIS | ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | IN-VITRO | POSTMENOPAUSAL OSTEOPOROSIS | ALENDRONATE TREATMENT | LONG-TERM RISEDRONATE | FEMORAL-HEAD | Jaw Diseases - chemically induced | Bone Neoplasms - drug therapy | Osteonecrosis - chemically induced | Diphosphonates - adverse effects | Humans | Diphosphonates | Bones | Dosage and administration | Postmenopausal women | Drug therapy | Health aspects | Necrosis | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Radiology, ISSN 1546-1440, 2010, Volume 7, Issue 10, pp. 754 - 773
As multidetector CT has come to play a more central role in medical care and as CT image quality has improved, there has been an increase in the frequency of...
Radiology | incidentaloma | adrenal nodule | pancreatic cyst | renal cyst | liver lesion | Incidental findings | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Tomography, X-Ray Computed - standards | Uncertainty | Carcinoma, Renal Cell - diagnostic imaging | Risk Assessment | Carcinoma, Renal Cell - pathology | Humans | Incidental Findings | Tomography, X-Ray Computed - methods | Carcinoma, Renal Cell - surgery | Adrenal Gland Neoplasms - diagnostic imaging | Radiography, Abdominal - standards | Liver Neoplasms - diagnostic imaging | Consensus | Kidney Neoplasms - surgery | Algorithms | Kidney Neoplasms - diagnostic imaging | Radiography, Abdominal - methods | Mammography - standards | Female | Kidney Neoplasms - pathology | Liver Neoplasms - pathology | Mammography - methods | Medical care | Medical colleges | CT imaging | Diagnostic imaging | Quality management
Radiology | incidentaloma | adrenal nodule | pancreatic cyst | renal cyst | liver lesion | Incidental findings | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Tomography, X-Ray Computed - standards | Uncertainty | Carcinoma, Renal Cell - diagnostic imaging | Risk Assessment | Carcinoma, Renal Cell - pathology | Humans | Incidental Findings | Tomography, X-Ray Computed - methods | Carcinoma, Renal Cell - surgery | Adrenal Gland Neoplasms - diagnostic imaging | Radiography, Abdominal - standards | Liver Neoplasms - diagnostic imaging | Consensus | Kidney Neoplasms - surgery | Algorithms | Kidney Neoplasms - diagnostic imaging | Radiography, Abdominal - methods | Mammography - standards | Female | Kidney Neoplasms - pathology | Liver Neoplasms - pathology | Mammography - methods | Medical care | Medical colleges | CT imaging | Diagnostic imaging | Quality management
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2010, Volume 85, Issue 9, pp. 806 - 813
OBJECTIVE To examine several dimensions of health-related quality of life (HRQL) in postmenopausal women who report previous fractures, and to provide...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | FINLAND | EUROQOL | FOREARM | ELDERLY MEN | CANADIAN MULTICENTER OSTEOPOROSIS | POSTMENOPAUSAL WOMEN | INCIDENT VERTEBRAL FRACTURES | HIP | SF-36 | Femoral Fractures - etiology | Age Factors | Spinal Fractures - psychology | Europe | Femoral Fractures - psychology | Humans | Middle Aged | Spinal Fractures - etiology | Hip Fractures - etiology | Linear Models | Fractures, Bone - etiology | Fractures, Bone - psychology | Osteoporosis - complications | Quality of Life | Female | Aged | Hip Fractures - psychology | Health Status | Longitudinal Studies | Osteoporosis - psychology | Women | Osteoporosis | Care and treatment | Arthritis | Postmenopausal women | Research | Diabetes | Diagnosis | Health aspects | Quality of life | Original
Internal Medicine | MEDICINE, GENERAL & INTERNAL | FINLAND | EUROQOL | FOREARM | ELDERLY MEN | CANADIAN MULTICENTER OSTEOPOROSIS | POSTMENOPAUSAL WOMEN | INCIDENT VERTEBRAL FRACTURES | HIP | SF-36 | Femoral Fractures - etiology | Age Factors | Spinal Fractures - psychology | Europe | Femoral Fractures - psychology | Humans | Middle Aged | Spinal Fractures - etiology | Hip Fractures - etiology | Linear Models | Fractures, Bone - etiology | Fractures, Bone - psychology | Osteoporosis - complications | Quality of Life | Female | Aged | Hip Fractures - psychology | Health Status | Longitudinal Studies | Osteoporosis - psychology | Women | Osteoporosis | Care and treatment | Arthritis | Postmenopausal women | Research | Diabetes | Diagnosis | Health aspects | Quality of life | Original
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2013, Volume 43, Issue 3, pp. 303 - 313
Abstract Objectives There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy....
Rheumatology | Economics | Cost–utility | Arthroplasty | Review | Cost-effectiveness | Osteoarthritis | Methods | Cost-utility | COST-EFFECTIVENESS ANALYSIS | RHEUMATOID-ARTHRITIS | TOTAL JOINT ARTHROPLASTY | EULAR-STANDING-COMMITTEE | HIP AND/OR KNEE | TASK-FORCE REPORT | EVIDENCE BASED RECOMMENDATIONS | RHEUMATOLOGY | TOTAL KNEE ARTHROPLASTY | SELECTIVE INHIBITORS | QUALITY-OF-LIFE | Cost-Benefit Analysis | Humans | Cost of Illness | Quality of Life | Osteoarthritis - economics | Consensus | Evidence-Based Medicine - economics | Osteoarthritis - therapy | Medical policy | Economic aspects | Osteoporosis | Medical colleges | Public health
Rheumatology | Economics | Cost–utility | Arthroplasty | Review | Cost-effectiveness | Osteoarthritis | Methods | Cost-utility | COST-EFFECTIVENESS ANALYSIS | RHEUMATOID-ARTHRITIS | TOTAL JOINT ARTHROPLASTY | EULAR-STANDING-COMMITTEE | HIP AND/OR KNEE | TASK-FORCE REPORT | EVIDENCE BASED RECOMMENDATIONS | RHEUMATOLOGY | TOTAL KNEE ARTHROPLASTY | SELECTIVE INHIBITORS | QUALITY-OF-LIFE | Cost-Benefit Analysis | Humans | Cost of Illness | Quality of Life | Osteoarthritis - economics | Consensus | Evidence-Based Medicine - economics | Osteoarthritis - therapy | Medical policy | Economic aspects | Osteoporosis | Medical colleges | Public health
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 950 - 961
Summary Background Doxorubicin chemotherapy is associated with cardiomyopathy. Dexrazoxane reduces cardiac damage during treatment with doxorubicin in children...
Hematology, Oncology and Palliative Medicine | ADULT SURVIVORS | ANTHRACYCLINE CARDIOTOXICITY | SECONDARY MALIGNANCIES | CHILDHOOD-CANCER | ADOLESCENT CANCER | ONCOLOGY | PEDIATRIC HODGKINS-DISEASE | CARDIAC TROPONIN-T | SERUM-LEVELS | 5-YEAR SURVIVORS | LATE MORTALITY | Cardiomyopathies - diagnostic imaging | Puerto Rico | Prospective Studies | United States | Humans | Antibiotics, Antineoplastic - adverse effects | Child, Preschool | Myocardial Contraction - drug effects | Cardiomyopathies - prevention & control | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Cardiomyopathies - physiopathology | Troponin T - blood | Time Factors | Ultrasonography | Female | Child | Cardiomyopathies - blood | Risk Assessment | Risk Factors | Ventricular Function, Left - drug effects | Kaplan-Meier Estimate | Survivors | Treatment Outcome | Biomarkers - blood | Razoxane - therapeutic use | Canada | Cardiovascular Agents - therapeutic use | Disease-Free Survival | Adolescent | Doxorubicin - adverse effects | Cardiomyopathies - chemically induced
Hematology, Oncology and Palliative Medicine | ADULT SURVIVORS | ANTHRACYCLINE CARDIOTOXICITY | SECONDARY MALIGNANCIES | CHILDHOOD-CANCER | ADOLESCENT CANCER | ONCOLOGY | PEDIATRIC HODGKINS-DISEASE | CARDIAC TROPONIN-T | SERUM-LEVELS | 5-YEAR SURVIVORS | LATE MORTALITY | Cardiomyopathies - diagnostic imaging | Puerto Rico | Prospective Studies | United States | Humans | Antibiotics, Antineoplastic - adverse effects | Child, Preschool | Myocardial Contraction - drug effects | Cardiomyopathies - prevention & control | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Cardiomyopathies - physiopathology | Troponin T - blood | Time Factors | Ultrasonography | Female | Child | Cardiomyopathies - blood | Risk Assessment | Risk Factors | Ventricular Function, Left - drug effects | Kaplan-Meier Estimate | Survivors | Treatment Outcome | Biomarkers - blood | Razoxane - therapeutic use | Canada | Cardiovascular Agents - therapeutic use | Disease-Free Survival | Adolescent | Doxorubicin - adverse effects | Cardiomyopathies - chemically induced
Journal Article
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2009, Volume 20, Issue 7, pp. S377 - S390
The field of interventional oncology with use of image-guided tumor ablation requires standardization of terminology and reporting criteria to facilitate...
Radiology | LIVER METASTASES | HEPATIC-TUMORS | SMALL HEPATOCELLULAR-CARCINOMA | THERMAL ABLATION | PERCUTANEOUS RADIOFREQUENCY ABLATION | TISSUE ABLATION | PERIPHERAL VASCULAR DISEASE | QUALITY IMPROVEMENT GUIDELINES | LASER-INDUCED THERMOTHERAPY | MICROWAVE COAGULATION THERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RENAL-CELL CARCINOMA | Catheter Ablation - methods | Lasers | Neoplasms - surgery | Humans | Terminology as Topic | Research Design - standards | Catheter Ablation - adverse effects | Hot Temperature
Radiology | LIVER METASTASES | HEPATIC-TUMORS | SMALL HEPATOCELLULAR-CARCINOMA | THERMAL ABLATION | PERCUTANEOUS RADIOFREQUENCY ABLATION | TISSUE ABLATION | PERIPHERAL VASCULAR DISEASE | QUALITY IMPROVEMENT GUIDELINES | LASER-INDUCED THERMOTHERAPY | MICROWAVE COAGULATION THERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RENAL-CELL CARCINOMA | Catheter Ablation - methods | Lasers | Neoplasms - surgery | Humans | Terminology as Topic | Research Design - standards | Catheter Ablation - adverse effects | Hot Temperature
Journal Article